HIV-1–infected mothers are recommended not to breastfeed their infants.
Fostemsavir is a prodrug of temsavir.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAME: Rukobia (ViiV)
- INDICATIONS: HIV-1 infection
- SYNONYM: Fostemsavir tromethamine
- CLASS: Antiretroviral, Antiviral
- HALF-LIFE: 11 hours
- FDA APPROVAL DATE: 07/02/2020
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Carbamazepine, CYP3A4 inducers, Enzalutamide, Mitotane, Phenytoin, Rifampin, St John's Wort - PREGNANCY: Insufficient human data to adequately assess a drug-associated risk of birth defects and miscarriage.
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
